Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

115.81
Delayed Data
As of Aug 28
 +1.11 / +0.97%
Today’s Change
64.08
Today|||52-Week Range
132.21
+13.52%
Year-to-Date

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.

Performance

1 month-14.67% 3 years+34.60%
3 months-13.39% 5 years+27.16%
1 year+17.38% Since inception+20.18%
Data through 08/28/2015

Quote Details

Previous close$114.70
Open day’s range114.02 – 115.88
Net asset value (NAV)106.77 (08/25/2015)
Daily volume141,698
Average volume (3 months)183,774
Data as of 3:59pm ET, 08/28/2015

Peer Comparisonvs. Health ETFs

 FBTCategory
Performance 5-yr return+27.16%+26.72%
Expense Gross exp ratio0.58%0.46%
Risk 5 year sharpe ratio1.381.76
Net assets$3.9B$2.2B
Average market cap$10.6B$38.7B
Average P/E21.026.0
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen3.75%
TECH Bio-Techne Corp3.65%
CRL Charles River Laboratories International Inc3.57%
-- 3.55%
NKTR Nektar Therapeutics3.50%
GRFS Grifols SA3.50%
VRTX Vertex Pharmaceuticals Inc3.48%
REGN Regeneron Pharmaceuticals3.48%
ALKS Alkermes Plc3.48%
Q Quintiles Transnational Holdings Inc3.46%

Partner Offers